SOURCE: CelLynx Group, Inc.

August 05, 2008 08:45 ET

CelLynx Group, Inc. Changes Name; Stock Ticker Symbol Changes to CYNX

EL DORADO HILLS, CA--(Marketwire - August 5, 2008) - CelLynx Group, Inc. today announced it has changed its corporate name, and it has changed its stock ticker symbol to CYNX (OTCBB: CYNX).

The Company had previously been named NorPac Technologies, Inc. (OTCBB: NRPT), and its stock symbol had previously been NRPT. The name and symbol change reflect NorPac's acquisition last month of all of the outstanding CelLynx common stock in a reverse merger transaction. Following that transaction, CelLynx became the Company's sole business, with CelLynx shareholders owning approximately 61.8 percent of the equity in the newly merged company, and the CelLynx officers replacing NorPac officers.

For more information regarding that transaction, please refer to the Company's Form 8-K filed July 30 with the SEC.

About CelLynx Group, Inc.

El Dorado Hills, California-based CelLynx is developing and plans to produce and market breakthrough, plug-and-play cell phone signal amplification technology. (See www.cellynx.com).

CelLynx has developed a product designed to boost cellular signal strength inside a home, office or vehicle simply by plugging in a single-piece "enhancer" unit next to a window. Unlike competing technologies, CelLynx's patent pending 5BARz™ technology does not require any installation, outside antennas or cables. It capitalizes on widespread customer dissatisfaction with indoor and vehicular cell phone coverage, and on the phenomenal worldwide growth of voice, data and video applications on cellular networks.

CelLynx technology is covered by worldwide patent applications, and is currently in pre-production prototype stage. CelLynx believes its technology represents a breakthrough in cellular signal amplification as the only technology designed to offer superior performance in an off the shelf plug-and-play unit -- one designed to be open platform, from GSM to CDMA, and mass produced and marketed worldwide at competitive prices. CelLynx is led by an exceptional team of accomplished, veteran industry professionals. Early CelLynx investors include Irvine, CA-based Palomar Ventures.

Forward-Looking Statement

This news release includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ include without limitation: whether the Company's technology will reach commercialization, the Company's limited operational history; requirement for and ability to raise capital; market acceptance of the Company's products; dependence on suppliers, third party manufacturers and other key vendors or partners; dependence on key personnel; continued enforceability of patent and trademark rights; and competition.

Many of these risk factors are set forth in the Company's periodic filings with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance upon these forward-looking statements that speak only as of the date of this press release. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact Information

  • Company Contact:
    Daniel Ash
    CEO
    Tel: (916) 941-1403
    Email: Email Contact